1. Komnenou AT, Georgopoulou I, Savvas I, et al. A retrospective study of presentation, treatment, and outcome of free-ranging raptors in Greece (1997–2000). J Zoo Wildl Med 2005; 36: 222–228.
2. Kelly A, Bland M. Admissions, diagnoses, and outcomes for Eurasian sparrowhawks (Accipiter nisus) brought to a wildlife rehabilitation center in England. J Raptor Res 2006; 40: 231–235.
3. Harris MC, Sleeman JM. Morbidity and mortality of bald eagles (Haliaeetus leucocephalus) and peregrine falcons (Falco peregrinus) admitted to the Wildlife Center of Virginia, 1993–2003. J Zoo Wildl Med 2007; 38: 62–66.
4. Deem SL, Terrell SP, Forrester DJ. A retrospective study of morbidity and mortality of raptors in Florida: 1988–1994. J Zoo Wildl Med 1998; 29: 160–164.
5. Wendell MD, Sleeman JM, Kratz G. Retrospective study of morbidity and mortality of raptors admitted to Colorado State University Veterinary Teaching Hospital during 1995 to 1998. J Wildl Dis 2002; 38: 101–106.
6. Morishita TY, Fullerton AT, Lowenstine LJ, et al. Morbidity and mortality in free-living raptorial birds of northern California: a retrospective study, 1983–1994. J Avian Med Surg 1998; 12: 78–81.
7. Mansour A, Khachaturian H, Lewis ME, et al. Anatomy of CNS opiod receptors. Trends Neurosci 1988; 11: 308–314.
8. Lamont L, Mathews K. Opioids, nonsteroidal anti-inflammatories, and analgesic adjuvants. In: Tranquilli W, Thurmon J, Grimm K, eds. Lumb & Jones' veterinary anesthesia. 4th ed. Ames, Iowa: Blackwell Publishing, 2007;241–272.
9. Pan Z, Hirakawa N, Fields HL. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin. Neuron 2000; 26: 515–522.
10. Reiner A, Brauth SE, Kitt CA, et al. Distribution of mu, delta, and kappa opiate receptor types in the forebrain and midbrain of pigeons. J Comp Neurol 1989; 280: 359–382.
11. Csillag A, Bourne RC, Stewart MG. Distribution of mu, delta, and kappa opioid receptor binding sites in the brain of the one-day-old domestic chick (Gallus domesticus): an in vitro quantitative autoradiographic study. J Comp Neurol 1990; 302: 543–551.
12. Khurshid N, Agarwal V, Iyengar S. Expression of mu- and delta-opioid receptors in song control regions of adult male zebra finches (Taenopygia guttata). J Chem Neuroanat 2009; 37: 158–169.
13. Curro TG, Brunson DB, Paul-Murphy J. Determination of the ED50 of isoflurane and evaluation of the analgesic properties of butorphanol in cockatoos (Cacatua spp.). Vet Surg 1994; 23: 429–433.
14. Paul-Murphy JR, Brunson DB, Miletic V. Analgesic effects of butorphanol and buprenorphine in conscious African grey parrots (Psittacus erithacus erithacus and Psittacus erithacus timneh). Am J Vet Res 1999; 60: 1218–1221.
15. Sladky KK, Krugner-Higby L, Meek-Walker E, et al. Serum concentrations and analgesic effects of liposome-encapsulated and standard butorphanol tartrate in parrots. Am J Vet Res 2006; 67: 775–781.
16. Sanchez-Migallon Guzman D, Kukanich B, Keuler NS, et al. Antinociceptive effects of nalbuphine hydrochloride in Hispaniolan Amazon parrots (Amazona ventralis). Am J Vet Res 2011; 72: 736–740.
17. Pavez JC, Hawkins MG, Pascoe PJ, et al. Effect of fentanyl target-controlled infusions on isoflurane minimum anaesthetic concentration and cardiovascular function in red-tailed hawks (Buteo jamaicensis). Vet Anaesth Analg 2011; 38: 344–351.
18. Guzman DS, Drazenovich TL, Olsen GH, et al. Evaluation of thermal antinociceptive effects after intramuscular administration of hydromorphone hydrochloride to American kestrels (Falco sparverius). Am J Vet Res 2013; 74: 817–822.
19. Sanchez-Migallon Guzman D, Drazenovich TL, KuKanich B, et al. Evaluation of thermal antinociceptive effects and pharmacokinetics after intramuscular administration of butorphanol tartrate to American kestrels (Falco sparverius). Am J Vet Res. 2014; 75:in press.
20. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs 2000; 60: 139–176.
21. Yoshimura M, Furue H. Mechanisms for the anti-nociceptive actions of the descending noradernergic and serotonergic systems in the spinal cord. J Pharmacol Sci 2006; 101: 107–117.
22. Tramadol [package insert]. Detroit: Caraco Pharmaceutical Laboratories Ltd, 2006
23. Leppert W, Luczak J. The role of tramadol in cancer pain treatment—a review. Support Care Cancer 2005; 13: 5–17.
24. Wu WN, McKown LA, Gauthier AD, et al. Metabolism of the analgesic drug, tramadol hydrochloride, in rat and dog. Xenobiotica 2001; 31: 423–441.
25. Gibson TP. Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCl. Am J Med 1996; 101: 47S–53S.
26. Lehmann KA. Tramadol for the management of acute pain. Drugs 1994; 47 (suppl 1): 19–32.
27. Sanchez-Migallon Guzman D, Souza MJ, Braun JM, et al. Antinociceptive effects after oral administration of tramadol hydrochloride in Hispaniolan Amazon parrots (Amazona ventralis). Am J Vet Res 2012; 73: 1148–1152.
28. Geelen S, Sanchez-Migallon Guzman D, Souza MJ, et al. Antinociceptive effects of tramadol hydrochloride after intravenous administration to Hispaniolan Amazon parrots (Amazona ventralis). Am J Vet Res 2013; 74: 201–206.
29. Cannon CZ, Kissling GE, Hoenerhoff MJ, et al. Evaluation of dosages and routes of administration of tramadol analgesia in rats using hot-plate and tail-flick tests. Lab Anim (NY) 2010; 39: 342–351.
30. Bianchi M, Panerai AE. Anti-hyperalgesic effects of tramadol in the rat. Brain Res 1998; 797: 163–166.
31. Mastrocinque S, Fantoni DT. A comparison of preoperative tramadol and morphine for the control of early postoperative pain in canine ovariohysterectomy. Vet Anaesth Analg 2003; 30: 220–228.
32. Pypendop BH, Siao KT, Ilkiw JE. Effects of tramadol hydrochloride on the thermal threshold in cats. Am J Vet Res 2009; 70: 1465–1470.
33. Brondani JT, Loureiro Luna SP, Beier SL, et al. Analgesic efficacy of perioperative use of vedaprofen, tramadol or their combination in cats undergoing ovariohysterectomy. J Feline Med Surg 2009; 11: 420–429.
34. Steagall PV, Taylor PM, Brondani JT, et al. Antinociceptive effects of tramadol and acepromazine in cats. J Feline Med Surg 2008; 10: 24–31.
35. Dhanjal JK, Wilson DV, Robinson E, et al. Intravenous tramadol: effects, nociceptive properties, and pharmacokinetics in horses. Vet Anaesth Analg 2009; 36: 581–590.
36. Baker BB, Sladky KK, Johnson SM. Evaluation of the analgesic effects of oral and subcutaneous tramadol administration in red-eared slider turtles. J Am Vet Med Assoc 2011; 238: 220–227.
37. Souza MJ, Gerhardt L, Cox S. Pharmacokinetics of repeated oral administration of tramadol hydrochloride in Hispaniolan Amazon parrots (Amazona ventralis). Am J Vet Res 2013; 74: 957–962.
38. Souza MJ, Sanchez-Migallon Guzman D, Paul-Murphy JR, et al. Pharmacokinetics after oral and intravenous administration of a single dose of tramadol hydrochloride to Hispaniolan Amazon parrots (Amazona ventralis). Am J Vet Res 2012; 73: 1142–1147.
39. Souza MJ, Martin-Jimenez T, Jones MP, et al. Pharmacokinetics of intravenous and oral tramadol in the bald eagle (Haliaeetus leucocephalus). J Avian Med Surg 2009; 23: 247–252.
40. Souza MJ, Martin-Jimenez T, Jones MP, et al. Pharmacokinetics of oral tramadol in red-tailed hawks (Buteo jamaicensis). J Vet Pharmacol Ther 2011; 34: 86–88.
41. Black PA, Cox SK, Macek M, et al. Pharmacokinetics of tramadol hydrochloride and its metabolite O-desmethyltramadol in peafowl (Pavo cristatus). J Zoo Wildl Med 2010; 41: 671–676.
42. Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev 2001; 53: 597–652.
43. Raffe MR. Animal models for the evaluation of analgesic agents. In: Short CE, Von Poznak A, eds. Animal pain. New York: Churchill Livingstone Co, 1992;453–458.
44. Hoppes S, Flammer K, Hoersch K, et al. Disposition and analgesic effects of fentanyl in the umbrella cockatoo (Cacatua alba). J Avian Med Surg 2003; 17: 124–130.
45. Paul-Murphy JR, Brunson DB, Miletic V. A technique for evaluating analgesia in conscious perching birds. Am J Vet Res 1999; 60: 1213–1217.
46. Machin KL. Avian pain: physiology and evaluation. Compend Contin Educ Pract Vet 2005; 27: 98–109.
47. Gentle MJ, Tilston V, McKeegan DE. Mechanothermal nociceptors in the scaly skin of the chicken leg. Neuroscience 2001; 106: 643–652.
48. Necker R, Reiner B. Temperature-sensitive mechanoreceptors, thermoreceptors and heat nociceptors in the feathered skin of pigeons. J Comp Physiol 1980; 135: 201–207.
49. AVMA. Use of placebo controls in assessment of new therapies for alleviation of acute pain in client-owned animals. Available at: www.avma.org/KB/Policies/Pages/Use-of-Placebo-Controls-in-Assessment-of-New-Therapies-for-Alleviation-of-Acute-Pain-in-Client-Owned-Animals.aspx. Accessed Sep 23, 2012.
50. Wagner DS, Johnson CE, Cichon-Hensley BK, et al. Stability of oral liquid preparations of tramadol in strawberry syrup and a sugar-free vehicle. Am J Health Syst Pharm 2003; 60: 1268–1270.
51. Cook CD, Barrett AC, Roach EL, et al. Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor. Psychopharmacology (Berl) 2000; 150: 430–442.
52. Morgan D, Mitzelfelt JD, Koerper LM, et al. Effects of morphine on thermal sensitivity in adult and aged rats. J Gerontol A Biol Sci Med Sci 2012; 67: 705–713.
53. Robertson SA, Wegner K, Lascelles BD. Antinociceptive and side-effects of hydromorphone after subcutaneous administration in cats. J Feline Med Surg 2009; 11: 76–81.
54. Smith LJ, KuKanich B, Hogan BK, et al. Pharmacokinetics of a controlled-release liposome-encapsulated hydromorphone administered to healthy dogs. J Vet Pharmacol Ther 2008; 31: 415–422.
55. KuKanich B, Schmidt BK, Krugner-Higby LA, et al. Pharmacokinetics and behavioral effects of oxymorphone after intravenous and subcutaneous administration to healthy dogs. J Vet Pharmacol Ther 2008; 31: 580–583.
56. Wegner K, Robertson SA. Dose-related thermal antinociceptive effects of intravenous hydromorphone in cats. Vet Anaesth Analg 2007; 34: 132–138.
57. KuKanich B, Papich MG. Pharmacokinetics of tramadol and the metabolite O-desmethyltramadol in dogs. J Vet Pharmacol Ther 2004; 27: 239–246.
58. Pypendop BH, Ilkiw JE. Pharmacokinetics of tramadol, and its metabolite O-desmethyl-tramadol, in cats. J Vet Pharmacol Ther 2008; 31: 52–59.
59. Hara K, Minami K, Sata T. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-d-aspartate receptors expressed in Xenopus oocytes. Anesth Analg 2005; 100: 1400–1405.
60. Pozzi A, Muir WW, Traverso F. Prevention of central sensitization and pain by N-methyl-d-aspartate receptor antagonists. J Am Vet Med Assoc 2006; 228: 53–60.
61. Petrenko AB, Yamakura T, Baba H, et al. The role of N-methyl-d-aspartate (NMDA) receptors in pain: a review. Anesth Analg 2003; 97: 1108–1116.
Advertisement
Objective—To evaluate the thermal antinociceptive and sedative effects and duration of action of tramadol hydrochloride after oral administration to American kestrels (Falco sparverius).
Animals—12 healthy 3-year-old American kestrels.
Procedures—Tramadol (5, 15, and 30 mg/kg) and a control suspension were administered orally in a masked randomized crossover experimental design. Foot withdrawal response to a thermal stimulus was determined 1 hour before (baseline) and 0.5, 1.5, 3, 6, and 9 hours after treatment. Agitation-sedation scores were determined 3 to 5 minutes before each thermal stimulus test.
Results—The lowest dose of tramadol evaluated (5 mg/kg) significantly increased the thermal foot withdrawal thresholds for up to 1.5 hours after administration, compared with control treatment values, and for up to 9 hours after administration, compared with baseline values. Tramadol at doses of 15 and 30 mg/kg significantly increased thermal thresholds at 0.5 hours after administration, compared with control treatment values, and up to 3 hours after administration, compared with baseline values. No significant differences in agitation-sedation scores were detected between tramadol and control treatments.
Conclusions and Clinical Relevance—Results indicated oral administration of 5 mg of tramadol/kg significantly increased thermal nociception thresholds for kestrels for 1.5 hours, compared with a control treatment, and 9 hours, compared with baseline values; higher doses resulted in less pronounced antinociceptive effects. Additional studies with other types of stimulation, formulations, dosages, routes of administration, and testing times would be needed to fully evaluate the analgesic and adverse effects of tramadol in kestrels and other avian species.
The authors thank Dr. Linda Barter for technical assistance.